Syphilis Treatment Guidelines
Primary and Secondary Syphilis
Benzathine penicillin G 2.4 million units IM as a single dose is the definitive treatment for primary and secondary syphilis in adults, achieving 90-100% cure rates. 1
- For children with acquired syphilis, administer benzathine penicillin G 50,000 units/kg IM (maximum 2.4 million units) as a single dose after CSF examination to exclude neurosyphilis 1
- All patients diagnosed with syphilis must be tested for HIV infection 1, 2
- Patients should be warned about Jarisch-Herxheimer reaction—an acute febrile reaction with headache and myalgia occurring within 24 hours of treatment 1
Penicillin-Allergic Patients (Non-Pregnant)
- Doxycycline 100 mg orally twice daily for 14 days is the preferred alternative 1
- Tetracycline 500 mg orally four times daily for 14 days is acceptable but adherence is typically worse 1
- Pregnant women with penicillin allergy must undergo desensitization followed by penicillin treatment—no exceptions 1, 3
Early Latent Syphilis (≤1 Year Duration)
Benzathine penicillin G 2.4 million units IM as a single dose is recommended for early latent syphilis. 1
- Early latent syphilis is defined by documented seroconversion within the past year, unequivocal symptoms of primary/secondary syphilis within the past year, or a sex partner with documented early syphilis 4, 1
- For penicillin-allergic non-pregnant adults: doxycycline 100 mg orally twice daily for 14 days 1
Late Latent Syphilis and Latent Syphilis of Unknown Duration
Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals, is the standard regimen. 1
- CSF examination is indicated before treatment if any of the following are present: neurologic or ophthalmic signs/symptoms, evidence of active tertiary syphilis, treatment failure, HIV infection with late latent syphilis, or nontreponemal titer ≥1:32 4, 1
- For penicillin-allergic non-pregnant adults: doxycycline 100 mg orally twice daily for 28 days, but only after CSF examination excludes neurosyphilis 1, 3
- If a dose is missed during weekly therapy, an interval of 10-14 days between doses may be acceptable before restarting; however, pregnant women must repeat the entire course if any dose is missed 1, 5
Neurosyphilis
Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours or continuous infusion) for 10-14 days is the first-line treatment. 1, 3
- Alternative outpatient regimen: procaine penicillin 2.4 million units IM once daily plus probenecid 500 mg orally four times daily for 10-14 days 1
- Procaine penicillin without probenecid is inadequate because it fails to achieve therapeutic CSF levels 1
- Some experts add benzathine penicillin G 2.4 million units IM weekly for up to 3 weeks after completing the IV course 1, 3
- Ocular syphilis (uveitis, neuroretinitis, optic neuritis) must be managed as neurosyphilis regardless of other clinical features 1, 3
Follow-Up for Neurosyphilis
- If CSF pleocytosis was present initially, repeat CSF examination every 6 months until cell count normalizes 1, 3
- Consider retreatment if CSF white blood cell count has not decreased after 6 months or if CSF remains abnormal after 2 years 4, 1
Tertiary Syphilis
Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at weekly intervals, is recommended for tertiary syphilis. 1
- CSF examination must be performed before initiating therapy for symptomatic tertiary syphilis (aortitis, gummas, iritis) 1, 3
- Some experts recommend treating all cardiovascular syphilis cases with the neurosyphilis regimen (IV aqueous crystalline penicillin G) 3
- Consultation with an infectious disease specialist is advised 3
Syphilis in Pregnancy
Pregnant women must receive the penicillin regimen appropriate for their stage of syphilis; treatment must occur more than 4 weeks before delivery for optimal outcomes. 1, 3
- All pregnant women with penicillin allergy must undergo desensitization and receive penicillin—penicillin is the only therapy with documented efficacy for preventing congenital syphilis 4, 1, 3
- Some experts recommend an additional dose of benzathine penicillin G 2.4 million units IM one week after the initial dose for pregnant women with primary, secondary, or early latent syphilis 4, 1, 3
- Erythromycin does not reliably cure fetal infection; tetracyclines cause maternal hepatotoxicity and fetal bone/tooth staining; azithromycin and ceftriaxone are inadequate alternatives 4, 3
Jarisch-Herxheimer Reaction in Pregnancy
- Treatment during the second half of pregnancy may precipitate preterm labor or fetal distress from Jarisch-Herxheimer reaction 4, 1
- Women should seek immediate obstetric attention if they notice contractions or decreased fetal movement after treatment 4, 1
- Consider fetal and contraction monitoring for 24 hours after treatment for early syphilis in women >20 weeks gestation 4
Screening Requirements
- Screen all pregnant women at first prenatal visit, during third trimester (28 weeks), and at delivery 4, 1, 2
- No infant should leave the hospital without documented maternal syphilis serology status 4, 1
Syphilis in HIV-Infected Patients
HIV-infected patients should receive the same penicillin regimens as HIV-negative patients for all stages of syphilis. 1, 3
- More intensive monitoring is mandatory: clinical and serologic evaluation at 3,6,9,12, and 24 months after treatment 4, 1, 3
- For late latent syphilis in HIV-infected patients, consider CSF examination before treatment to exclude neurosyphilis 4, 1, 3
- If nontreponemal titers do not decline fourfold within 3 months for primary/secondary syphilis, perform CSF examination and consider retreatment 1, 3
- When CSF is normal after treatment failure, most experts retreat with benzathine penicillin G 7.2 million units (three weekly doses) 4, 1
- Penicillin-allergic HIV-infected patients should undergo skin testing and desensitization, then receive penicillin 4
Follow-Up and Treatment Response Monitoring
Primary and Secondary Syphilis
- Perform quantitative nontreponemal serologic tests (RPR or VDRL) at 6 and 12 months after treatment 1, 3
- Treatment success is defined as a fourfold (two-dilution) decline in nontreponemal titers within 6 months 1, 3
Latent Syphilis
- Repeat quantitative nontreponemal tests at 6,12,18, and 24 months 1, 3
- Expect fourfold decline within 12-24 months for late syphilis 1, 3
Treatment Failure Indicators
- Persistent or recurring signs/symptoms of syphilis 1, 3
- Sustained fourfold increase in nontreponemal titers 1, 3
- Failure of initially high titer (≥1:32) to decline fourfold within 6-12 months for early syphilis or 12-24 months for late syphilis 1, 3
Management of Treatment Failure
- Perform HIV testing if not previously done 1
- Conduct CSF examination to rule out neurosyphilis 1, 3
- Re-treat with benzathine penicillin G 7.2 million units (three weekly doses) if CSF is normal 1, 3
- If CSF indicates neurosyphilis, treat according to neurosyphilis recommendations 4
Management of Sexual Partners
Presumptively treat sexual partners exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis, even if seronegative. 1, 3
- Time periods for at-risk partners: 3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis, and 1 year for early latent syphilis 1, 3
- Partners exposed >90 days before diagnosis should be treated presumptively if serologic results are not immediately available and follow-up is uncertain 1, 3
- Long-term partners of patients with late syphilis should undergo clinical and serologic evaluation 3
Alternative Regimens: Critical Limitations
Ceftriaxone
- Ceftriaxone 1 gram IM/IV daily for 10-14 days may be considered for early syphilis based on randomized trial data showing comparable efficacy to benzathine penicillin 1, 5
- For neurosyphilis, ceftriaxone 2 grams daily IV for 10-14 days has very limited supporting data 1
- Patients with severe penicillin allergy (Stevens-Johnson syndrome) may also be allergic to ceftriaxone as both are beta-lactam antibiotics 1
- Evidence for ceftriaxone in late latent and tertiary syphilis is extremely limited 1
Azithromycin
- Azithromycin should NOT be used in the United States due to widespread macrolide resistance and documented treatment failures 1, 3
Erythromycin
- Erythromycin 500 mg orally four times daily for 14 days is less effective and should be used only when strict compliance and reliable follow-up can be guaranteed 1
Important Clinical Pitfalls to Avoid
- Do not use oral penicillin preparations—they are ineffective for syphilis treatment 1
- Do not switch between different nontreponemal testing methods (RPR vs VDRL) when monitoring serologic response, as results cannot be directly compared 1, 3
- Do not rely solely on treponemal test antibody titers to assess treatment response—they correlate poorly with disease activity 1
- Do not assume new genital lesions after recent treatment represent treatment failure without appropriate serologic confirmation at the required time interval 1
- Remember that 15-25% of successfully treated patients remain "serofast" with persistent low titers (<1:8) that do not indicate treatment failure 1
- Sequential RPR tests should use the same method and ideally the same laboratory, as RPR titers are often slightly higher than VDRL titers 3